{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T12:03:53Z","timestamp":1776513833612,"version":"3.51.2"},"reference-count":90,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T00:00:00Z","timestamp":1666137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"FEDER\u2014Fundo Europeu de Desenvolvimento Regional","award":["UIDB\/4255\/2020"],"award-info":[{"award-number":["UIDB\/4255\/2020"]}]},{"name":"FEDER\u2014Fundo Europeu de Desenvolvimento Regional","award":["IF\/00092\/2014\/CP1255\/CT0004"],"award-info":[{"award-number":["IF\/00092\/2014\/CP1255\/CT0004"]}]},{"name":"FCT\u2014Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["UIDB\/4255\/2020"],"award-info":[{"award-number":["UIDB\/4255\/2020"]}]},{"name":"FCT\u2014Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","award":["IF\/00092\/2014\/CP1255\/CT0004"],"award-info":[{"award-number":["IF\/00092\/2014\/CP1255\/CT0004"]}]},{"name":"FCT and FEDER (European Unio","award":["UIDB\/4255\/2020"],"award-info":[{"award-number":["UIDB\/4255\/2020"]}]},{"name":"FCT and FEDER (European Unio","award":["IF\/00092\/2014\/CP1255\/CT0004"],"award-info":[{"award-number":["IF\/00092\/2014\/CP1255\/CT0004"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>The use of FDA-approved drugs for new indications represents a faster and more economical way to find novel therapeutic agents for cancer therapy, compared to the development of new drugs. Repurposing drugs is advantageous in a pharmacological context since these drugs already have extensive data related to their pharmacokinetics, facilitating their approval process for different diseases. Several studies have reported the promising anticancer effects of sertraline, both alone and combined, in different types of cancer cell lines. Here, we performed a literature review on the anticancer potential of sertraline against different human cancer cells, more specifically in lung, colorectal, breast, hepatocellular, leukemia, brain, skin, oral, ovarian, and prostate cancer. Taken together, these findings suggest that sertraline decreases cell viability, proliferation, migration, and invasion, induces apoptosis, and causes cell cycle arrest in different types of cancer cells, besides being an established P-glycoprotein modulator. It was also found that this drug is able to modulate autophagy, cause DNA fragmentation, and induce radical oxygen species (ROS) formation. Moreover, it was found this drug targets important cellular pathways involved in tumorigeneses such as the TNF-MAP4K4-JNK pathway, the antiapoptotic pathway PI3K\/Akt\/mTOR, and the AMPK\/mTOR axis. This drug also interferes with the TCTP\/P53 feedback loop and with the cytosolic free Ca2+ levels. Together, these results suggest that sertraline may be a promising compound for further evaluation in novel cancer therapies.<\/jats:p>","DOI":"10.3390\/biom12101513","type":"journal-article","created":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T20:32:23Z","timestamp":1666211543000},"page":"1513","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Antidepressant Drug Sertraline against Human Cancer Cells"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1420-5042","authenticated-orcid":false,"given":"Diana","family":"Duarte","sequence":"first","affiliation":[{"name":"OncoPharma Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"},{"name":"Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal"},{"name":"CINTESIS@RISE, Faculty of Medicine, University of Porto, Alameda Professor Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1283-1042","authenticated-orcid":false,"given":"Nuno","family":"Vale","sequence":"additional","affiliation":[{"name":"OncoPharma Research Group, Center for Health Technology and Services Research (CINTESIS), Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"},{"name":"CINTESIS@RISE, Faculty of Medicine, University of Porto, Alameda Professor Hern\u00e2ni Monteiro, 4200-319 Porto, Portugal"},{"name":"Department of Community Medicine, Health Information and Decision (MEDCIDS), Faculty of Medicine, University of Porto, Rua Doutor Pl\u00e1cido da Costa, 4200-450 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer Statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/jnci\/djab122","article-title":"Association of the COVID-19 Pandemic With Patterns of Statewide Cancer Services","volume":"114","author":"Yabroff","year":"2022","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"172784","DOI":"10.1016\/j.ejphar.2019.172784","article-title":"Old Wine in New Bottles: Drug Repurposing in Oncology","volume":"866","author":"Antoszczak","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/jamainternmed.2017.3601","article-title":"Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval","volume":"177","author":"Prasad","year":"2017","journal-title":"JAMA Intern. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrd.2016.15","article-title":"2015 FDA Drug Approvals","volume":"15","author":"Mullard","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/jphp.13273","article-title":"Drug Repositioning: A Brief Overview","volume":"72","author":"Jourdan","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3332\/ecancer.2014.485","article-title":"The Repurposing Drugs in Oncology (ReDO) Project","volume":"8","author":"Pantziarka","year":"2014","journal-title":"Ecancermedicalscience"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.trecan.2017.06.007","article-title":"Repurposing Drugs in Oncology: Next Steps","volume":"3","author":"Verbaanderd","year":"2017","journal-title":"Trends Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1586\/ecp.12.79","article-title":"Drug Repurposing a Reality: From Computers to the Clinic","volume":"6","author":"Issa","year":"2014","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/S0140-6736(04)16308-3","article-title":"Thalidomide","volume":"363","author":"Franks","year":"2004","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev-med-062613-093128","article-title":"Metformin in Cancer Treatment and Prevention","volume":"66","author":"Morales","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"104787","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-Approved Drug Ivermectin Inhibits the Replication of SARS-CoV-2 in Vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: Chloroquine Phosphate Has Shown Apparent Efficacy in Treatment of COVID-19 Associated Pneumonia in Clinical Studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci. Trends"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"104762","DOI":"10.1016\/j.antiviral.2020.104762","article-title":"Of Chloroquine and COVID-19","volume":"177","author":"Touret","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"105932","DOI":"10.1016\/j.ijantimicag.2020.105932","article-title":"Chloroquine and Hydroxychloroquine as Available Weapons to Fight COVID-19","volume":"55","author":"Colson","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1200\/JCO.2011.39.7372","article-title":"Evidence-Based Treatment of Depression in Patients with Cancer","volume":"30","author":"Li","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3747\/co.2007.146","article-title":"Treatment of Depression in Cancer Patients","volume":"14","author":"Rodin","year":"2007","journal-title":"Curr. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/annonc\/mdx526","article-title":"The Use of Antidepressants in Oncology: A Review and Practical Tips for Oncologists","volume":"29","author":"Grassi","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s12272-018-1017-3","article-title":"Antipsychotic Dopamine Receptor Antagonists, Cancer, and Cancer Stem Cells","volume":"41","author":"Roney","year":"2018","journal-title":"Arch. Pharm. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mehy.2012.03.026","article-title":"Antipsychotic Drugs: Pro-Cancer or Anti-Cancer? A Systematic Review","volume":"79","author":"Fond","year":"2012","journal-title":"Med. Hypotheses"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e1111","DOI":"10.1038\/cddis.2014.56","article-title":"Harnessing the Lysosome-Dependent Antitumor Activity of Phenothiazines in Human Small Cell Lung Cancer","volume":"5","author":"Zong","year":"2014","journal-title":"Cell Death Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"127ra36","DOI":"10.1126\/scitranslmed.3003016","article-title":"Anti-Invasive Adjuvant Therapy with Imipramine Blue Enhances Chemotherapeutic Efficacy Against Glioma","volume":"4","author":"Munson","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4081\/oncol.2019.411","article-title":"Prospects for Repurposing CNS Drugs for Cancer Treatment","volume":"13","author":"Abdelaleem","year":"2019","journal-title":"Oncol. Rev."},{"key":"ref_24","unstructured":"Costa, P., McCrae, R., Cloninger, C., Svrakic, D., Sadock, B., Sadock, V., Adams, R., and Cultbertson, J. (2000). Kaplan and Sadock\u2019s Comprehensive Textbook of Psychiatry, Wolters Kluwer."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.2174\/0929867327666200907141452","article-title":"Antidepressants and Antipsychotic Agents as Repurposable Oncological Drug Candidates","volume":"28","author":"Antoszczak","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1007\/s10439-014-1086-5","article-title":"Permeability Analysis of Neuroactive Drugs through a Dynamic Microfluidic in Vitro Blood-Brain Barrier Model","volume":"42","author":"Booth","year":"2014","journal-title":"Ann. Biomed. Eng."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1248\/bpb.31.231","article-title":"Sertraline and Its Metabolite Desmethylsertraline, but Not Bupropion or Its Three Major Metabolites, Have High Affinity for P-Glycoprotein","volume":"31","author":"Wang","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/FPC.0000000000000392","article-title":"PharmGKB Summary: Sertraline Pathway, Pharmacokinetics","volume":"30","author":"Huddart","year":"2020","journal-title":"Pharmacogenet. Genom."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4088\/JCP.v68n0222a","article-title":"Handbook of Psychiatric Drug Therapy, 5th Ed","volume":"68","author":"Chiles","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0022-5347(01)67288-4","article-title":"Growth-Inhibitory Effects of Serotonin Uptake Inhibitors on Human Prostate Carcinoma Cell Lines","volume":"154","author":"Abdul","year":"1995","journal-title":"J. Urol."},{"key":"ref_31","first-page":"161","article-title":"Estimation of Apoptosis in C6 Glioma Cells Treated with Antidepressants","volume":"46","author":"Rittich","year":"1997","journal-title":"Physiol. Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"029","DOI":"10.1385\/JMN:27:1:029","article-title":"Differential Induction of Apoptosis by Antidepressants in Glioma and Neuroblastoma Cell Lines: Evidence for p-c-Jun, Cytochrome c, and Caspase-3 Involvement","volume":"27","author":"Levkovitz","year":"2005","journal-title":"J. Mol. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-3956(02)00061-4","article-title":"Differential Effects of Fluoxetine and Imipramine on the Phosphorylation of the Transcription Factor CREB and Cell-Viability","volume":"37","author":"Koch","year":"2003","journal-title":"J. Psychiatr. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.bcp.2007.07.017","article-title":"Selective Serotonin Reuptake Inhibitors-A New Modality for the Treatment of Lymphoma\/Leukaemia?","volume":"74","author":"Schuster","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"7562","DOI":"10.1158\/0008-5472.CAN-03-4046","article-title":"Fluoxetine Inhibits Multidrug Resistance Extrusion Pumps and Enhances Responses to Chemotherapy in Syngeneic and in Human Xenograft Mouse Tumor Models","volume":"64","author":"Peer","year":"2004","journal-title":"Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"8702","DOI":"10.1073\/pnas.90.18.8702","article-title":"A Model for Tumor Suppression Using H-1 Parvovirus","volume":"90","author":"Telerman","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"15364","DOI":"10.1073\/pnas.0406776101","article-title":"Translationally Controlled Tumor Protein Is a Target of Tumor Reversion","volume":"101","author":"Tuynder","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_38","first-page":"1","article-title":"Progressive Transfusion and Growth Factor Independence with Adjuvant Sertraline in Low Risk Myelodysplastic Syndrome Treated with an Erythropoiesis Stimulating Agent and Granulocyte-Colony Stimulating Factor","volume":"4","author":"Nautiyal","year":"2015","journal-title":"Leuk. Res. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"vi213","DOI":"10.1093\/neuonc\/nox168.862","article-title":"RARE-09. Minimally Toxic Multimodal and Polypharmacological Therapy In Treatment of Diffuse Midline Glioma","volume":"19","author":"Salacz","year":"2017","journal-title":"Neuro-oncology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e98921","DOI":"10.1172\/jci.insight.98921","article-title":"Repurposing Sertraline Sensitizes Non-Small Cell Lung Cancer Cells to Erlotinib by Inducing Autophagy","volume":"3","author":"Jiang","year":"2018","journal-title":"JCI Insight"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3892\/ijmm.2020.4635","article-title":"Inhibition of Autophagy Flux by Sertraline Attenuates TRAIL Resistance in Lung Cancer via Death Receptor 5 Upregulation","volume":"46","author":"Zinnah","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/CCO.0b013e32835b7d21","article-title":"Lessons from Tumor Reversion for Cancer Treatment","volume":"25","author":"Amson","year":"2013","journal-title":"Curr. Opin. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nm.2546","article-title":"Reciprocal Repression between P53 and TCTP","volume":"18","author":"Amson","year":"2011","journal-title":"Nat. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1126\/science.7542803","article-title":"Molecular Identification of an IgE-Dependent Histamine-Releasing Factor","volume":"269","author":"MacDonald","year":"1995","journal-title":"Science"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-67591-6_1","article-title":"Introduction: How We Encountered TCTP and Our Purpose in Studying It","volume":"64","author":"Telerman","year":"2017","journal-title":"Results Probl. Cell Differ."},{"key":"ref_46","first-page":"277","article-title":"Evaluation of the Potential Anti-Cancer Activity of the Antidepressant Sertraline in Human Colon Cancer Cell Lines and in Colorectal Cancer-Xenografted Mice","volume":"33","author":"Zolokov","year":"2008","journal-title":"Int. J. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Duarte, D., Cardoso, A., and Vale, N. (2021). Synergistic Growth Inhibition of HT-29 Colon and MCF-7 Breast Cancer Cells with Simultaneous and Sequential Combinations of Antineoplastics and CNS Drugs. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22147408"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Duarte, D., R\u00eama, A., Amorim, I., and Vale, N. (2022). Drug Combinations: A New Strategy to Extend Drug Repurposing and Epithelial-Mesenchymal Transition in Breast and Colon Cancer Cells. Biomolecules, 12.","DOI":"10.3390\/biom12020190"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Duarte, D., Falc\u00e3o, S.I., El Mehdi, I., Vilas-Boas, M., Vale, N., El Mehdi, I., Vilas-Boas, M., and Vale, N. (2022). Honeybee Venom Synergistically Enhances the Cytotoxic Effect of CNS Drugs in HT-29 Colon and MCF-7 Breast Cancer Cell Lines. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14030511"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13046-021-01971-1","article-title":"Targeting SERT Promotes Tryptophan Metabolism: Mechanisms and Implications in Colon Cancer Treatment","volume":"40","author":"Ye","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"i5309","DOI":"10.1136\/bmj.i5309","article-title":"Revisiting the Drug Interaction between Tamoxifen and SSRI Antidepressants","volume":"354","author":"Juurlink","year":"2016","journal-title":"BMJ"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1158\/0008-5472.CAN-09-4072","article-title":"The Antidepressant Sertraline Inhibits Translation Initiation by Curtailing Mammalian Target of Rapamycin Signaling","volume":"70","author":"Lin","year":"2010","journal-title":"Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"842.3","DOI":"10.1096\/fasebj.28.1_supplement.842.3","article-title":"Cytotoxic Effects of Selective Serotonin- and Serotonin-Norepinephrine Reuptake Inhibitors on Human Metastatic Breast Cancer Cell Line, MCF-7 (842.3)","volume":"28","author":"Bavadekar","year":"2014","journal-title":"FASEB J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"32101","DOI":"10.18632\/oncotarget.16646","article-title":"Serotonergic System Antagonists Target Breast Tumor Initiating Cells and Synergize with Chemotherapy to Shrink Human Breast Tumor Xenografts","volume":"8","author":"Gwynne","year":"2017","journal-title":"Oncotarget"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"53137","DOI":"10.18632\/oncotarget.10614","article-title":"Serotonin Transporter Antagonists Target Tumor-Initiating Cells in a Transgenic Mouse Model of Breast Cancer","volume":"7","author":"Hallett","year":"2016","journal-title":"Oncotarget"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1158\/1535-7163.MCT-20-0480","article-title":"Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine\/Glycine Synthesis\u2013Addicted Breast Tumor Growth","volume":"20","author":"Geeraerts","year":"2021","journal-title":"Mol. Cancer Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/toxsci\/kft254","article-title":"Sertraline, an Antidepressant, Induces Apoptosis in Hepatic Cells Through the Mitogen-Activated Protein Kinase Pathway","volume":"137","author":"Chen","year":"2014","journal-title":"Toxicol. Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1248\/bpb.b15-00128","article-title":"Comparison of the Anti-Tumor Effects of Selective Serotonin Reuptake Inhibitors as Well as Serotonin and Norepinephrine Reuptake Inhibitors in Human Hepatocellular Carcinoma Cells","volume":"38","author":"Kuwahara","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.euroneuro.2009.06.003","article-title":"Proapoptotic and Chemosensitizing Effects of Selective Serotonin Reuptake Inhibitors on T Cell Lymphoma\/Leukemia (Jurkat) in Vitro","volume":"19","author":"Amit","year":"2009","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1080\/10428194.2017.1287358","article-title":"Sertraline Exerts Its Antitumor Functions through Both Apoptosis and Autophagy Pathways in Acute Myeloid Leukemia Cells","volume":"58","author":"Xia","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"ref_63","first-page":"1043","article-title":"In Vitro Novel Combinations of Psychotropics and Anti-Cancer Modalities in U87 Human Glioblastoma Cells","volume":"37","author":"Tzadok","year":"2010","journal-title":"Int. J. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1755-148X.2008.00481.x","article-title":"The Antidepressant Sertraline Downregulates Akt and Has Activity against Melanoma Cells","volume":"21","author":"Reddy","year":"2008","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/bjc.2017.230","article-title":"TCTP as a Therapeutic Target in Melanoma Treatment","volume":"117","author":"Hamasaki","year":"2017","journal-title":"Br. J. Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1177\/0960327110396523","article-title":"The Mechanism of Sertraline-Induced [Ca2+]i Rise in Human OC2 Oral Cancer Cells","volume":"30","author":"Chien","year":"2011","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.canlet.2014.08.026","article-title":"Modulating Cancer Multidrug Resistance by Sertraline in Combination with a Nanomedicine","volume":"354","author":"Drinberg","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1742-7843.2011.00690.x","article-title":"The Mechanism of Sertraline-Induced [Ca(2+) ](i) Rise in Human PC3 Prostate Cancer Cells","volume":"109","author":"Huang","year":"2011","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_69","first-page":"2043","article-title":"Repurposing Antidepressant Sertraline as a Pharmacological Drug to Target Prostate Cancer Stem Cells: Dual Activation of Apoptosis and Autophagy Signaling by Deregulating Redox Balance","volume":"10","author":"Chinnapaka","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"127997","DOI":"10.1016\/j.bmcl.2021.127997","article-title":"Discovery of Sertraline and Its Derivatives Able to Combat Drug-Resistant Gastric Cancer Cell via Inducing Apoptosis","volume":"41","author":"Mu","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/01480545.2012.710625","article-title":"Effect of Sertraline on [Ca2+](i) and Viability of Human MG63 Osteosarcoma Cells","volume":"36","author":"Lin","year":"2013","journal-title":"Drug Chem. Toxicol."},{"key":"ref_72","first-page":"CD006117","article-title":"Sertraline versus Other Antidepressive Agents for Depression","volume":"4","author":"Cipriani","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1503\/cmaj.080697","article-title":"Neurobiological Mechanisms in Major Depressive Disorder","volume":"180","author":"Rot","year":"2009","journal-title":"CMAJ"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/FPC.0b013e32833132cb","article-title":"Selective Serotonin Reuptake Inhibitors Pathway","volume":"19","author":"Sangkuhl","year":"2009","journal-title":"Pharmacogenet. Genom."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0893-133X(95)00240-E","article-title":"Effect of Pindolol on the Function of Pre- and Postsynaptic 5-HT1A Receptors: In Vivo Microdialysis and Electrophysiological Studies in the Rat Brain","volume":"15","author":"Romero","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0166-2236(96)10037-0","article-title":"Acceleration of the Effect of Selected Antidepressant Drugs in Major Depression by 5-HT1A Antagonists","volume":"19","author":"Artigas","year":"1996","journal-title":"Trends Neurosci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/sj.npp.1300686","article-title":"Effects of Acute and Long-Term Administration of Escitalopram and Citalopram on Serotonin Neurotransmission: An in Vivo Electrophysiological Study in Rat Brain","volume":"30","author":"Chouvet","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0893-133X(00)00175-5","article-title":"Desensitization of 5-HT1A Autoreceptors by a Low Chronic Fluoxetine Dose Effect of the Concurrent Administration of WAY-100635","volume":"24","author":"Romero","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jpsychires.2007.05.004","article-title":"Serotonin-1A Autoreceptor Binding in the Dorsal Raphe Nucleus of Depressed Suicides","volume":"42","author":"Boldrini","year":"2008","journal-title":"J. Psychiatr. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/sj.npp.1300992","article-title":"Higher 5-HT1A Receptor Binding Potential during a Major Depressive Episode Predicts Poor Treatment Response: Preliminary Data from a Naturalistic Study","volume":"31","author":"Parsey","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejphar.2010.08.026","article-title":"Sertraline Increases Extracellular Levels Not Only of Serotonin, but Also of Dopamine in the Nucleus Accumbens and Striatum of Rats","volume":"647","author":"Kitaichi","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/pds.4345","article-title":"A Combined Connectivity Mapping and Pharmacoepidemiology Approach to Identify Existing Medications with Breast Cancer Causing or Preventing Properties","volume":"27","author":"Busby","year":"2018","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/pon.4493","article-title":"SSRIs Associated with Decreased Risk of Hepatocellular Carcinoma: A Population-Based Case-Control Study","volume":"27","author":"Chan","year":"2018","journal-title":"Psychooncology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"33179","DOI":"10.18632\/oncotarget.8891","article-title":"SSRI Use and Clinical Outcomes in Epithelial Ovarian Cancer","volume":"7","author":"Christensen","year":"2016","journal-title":"Oncotarget"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/ijc.30919","article-title":"Use of Antidepressants and Risk of Epithelial Ovarian Cancer","volume":"141","author":"Dehlendorff","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_86","first-page":"22","article-title":"SSRI Antidepressant Medications: Adverse Effects and Tolerability","volume":"3","author":"Ferguson","year":"2001","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"ref_87","first-page":"1525","article-title":"The Effects of Sertraline on Blood Lipids, Glucose, Insulin and HBA1C Levels: A Prospective Clinical Trial on Depressive Patients","volume":"16","author":"Kesim","year":"2011","journal-title":"J. Res. Med. Sci."},{"key":"ref_88","unstructured":"(2022, September 26). Sertraline: MedlinePlus Drug Information, Available online: https:\/\/medlineplus.gov\/druginfo\/meds\/a697048.html."},{"key":"ref_89","unstructured":"(2022, September 21). A Proof-of-Concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma\u2014No Study Results Posted\u2014ClinicalTrials.Gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT02770378?term=NCT02770378&draw=2&rank=1."},{"key":"ref_90","unstructured":"(2022, September 21). Sertraline and Cytosine Arabinoside in Adults With Relapsed and Refractory AML\u2014Full Text View\u2014ClinicalTrials.Gov, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT02891278?term=NCT02891278&draw=2&rank=1."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/10\/1513\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:57:15Z","timestamp":1760144235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/12\/10\/1513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,19]]},"references-count":90,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["biom12101513"],"URL":"https:\/\/doi.org\/10.3390\/biom12101513","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,19]]}}}